The Maltese Release Company - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Maltese Release Company (TMRC) is a recently established, privately owned company, located in Malta in the pharmaceutical industrial park of Hal Far.

TMRC was born from a Joint Venture between COMBINO PHARM and ALFRED E. TIEFENBACHER, to offer a vast range of services to pharmaceutical companies.

The strategic location of TMRC permits us to perform EU-GMP testing and release of pharmaceutical products even before the end of patent term, allowing our clients the great opportunity to start selling products in the EU market from day one, a huge advantage when compared to other competitors.

The company counts on a diverse team of highly skilled and experienced individuals both in quality control analysis as well as quality assurance.

For more information please contact us info@themalteserelease.com.mt or visit www.themalteserelease.com.mt

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
FindPharma Custom Search

Click here